show episodes
 
Interviews with authors of articles from JAMA Dermatology. JAMA Dermatology covers research on the skin, its diseases, and their treatment. Our mission is to explicate the structure and function of the skin and its diseases and the art of using this information to deliver optimal medical and surgical care to the patient. We attempt to enhance the understanding of cutaneous pathophysiology and improve the clinician's ability to diagnose and treat skin disorders.
  continue reading
 
Artwork
 
Learn along side the Vanderbilt Internal Medicine Residents: Knowledge and best practice in this field are constantly changing. As new research and experience broaden our understanding, changes in research methods or professional practices may become necessary. Practitioners and researchers must always rely on their own experience and knowledge in evaluating their patients when using any information or methods described herein. In using such information or methods, they should be mindful of ...
  continue reading
 
Loading …
show series
 
Interview with Kathryn T. Shahwan, MD, author of Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma: Expert Panel Guidelines from ITSCC. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma…
  continue reading
 
Interview with Sudha Chaturvedi, PhD, author of Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of Trichophyton indotineae. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of Trichophyton indotineae
  continue reading
 
Interview with Steven R. Cohen, MD, MPH, author of Efficacy and Durability of Intravenous Ertapenem Therapy for Recalcitrant Hidradenitis Suppurativa. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Efficacy and Durability of Intravenous Ertapenem Therapy for Recalcitrant Hidradenitis Suppurativa…
  continue reading
 
The NHS is paying increasing attention to leadership within clinical teams. Leadership training can be delivered in different ways, for example, to the team leader alone or to all team members. However, it is not clear which approaches work best. Researchers looked at leadership training for surgeons, and asked what makes training effective. In thi…
  continue reading
 
Professor Martin Tobin and Dr Catherine John talk to Professor Turi King about the first 10 years of the NIHR Leicester EXCEED Study, from its original aims through to the research questions its data is helping to answer today. EXCEED (Extended Cohort for E-health, Environment and DNA) is a longitudinal health study that looks at the causes of long…
  continue reading
 
Interview with Kathleen F. Kerr, PhD, author of Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions…
  continue reading
 
Discover how the UK is taking vaccine research delivery to the next level with NIHR support. During the pandemic the UK demonstrated its ability to deliver vaccine trials at pace and scale. In this podcast you will hear how that UK expertise and capability is being harnessed to drive rapid development of future vaccines. Professors Andrew Ustianows…
  continue reading
 
This week EURACTIV's health reporter Marta Iraola talks to Dr. Emilie Karafillakis about vaccine confidence in Europe and what is behind people's lack of trust in vaccination and public health campaigns. In this episode, the health team reunites before the summer to say goodbye to this podcast as from September health topics will be covered under B…
  continue reading
 
In this episode we are exploring public health research - what it is and how it can help people to live healthier and longer lives. For many people their only experience of public health research will be related to infection prevention and protection during the COVID19 pandemic. But that's just one area of public health research and this podcast ex…
  continue reading
 
From YouTube-recommended videos to facial recognition used to unlock smartphones, AI is already being used on a daily basis. The healthcare sector is not an exception as its ability to process vast amounts of medical data helps in diagnostics and medical image analysis. To better understand where AI is already used and what potential it holds, EURA…
  continue reading
 
As the European Parliament debates how European health data space should be shaped, EURACTIV talks with the co-rapporteur of the file, Croatian MEP Tomislav Sokol (EPP), touching on primary and secondary use of data, the reasons why parliament supports the opt-out option and what is left to discuss before the discussions can start with the Council.…
  continue reading
 
European Health Data Space (EHDS) focuses on the primary and secondary use of data. While the primary use of data is data used by citizens and healthcare professionals at the national and EU levels the secondary data is to be used by researchers, policy makers and pharma. The Commission's proposal does not include any say for patients regarding the…
  continue reading
 
On the occasion of the first Healthcare Forum, which took place in Wąsowo, Poland last week, Euractiv spoke with the Regional Director of WHO/Europe, Dr Hans Kluge. In this interview, Dr. Kluge looked back on his meeting with the Polish and Ukrainian Ministers of Health about the Healthy Reconstruction of Ukraine. He dug into the physical and menta…
  continue reading
 
This week EURACTIV'S health team explores why fertility is decreasing across the globe, what challenges people face when they want children and the situation of fertility treatments in Europe. For that, Health Reporter Marta Iraola talks with Dr Carlos Calhaz-Jorge, a specialist in obstetrics and gynaecology and chair of the European Society for Hu…
  continue reading
 
This week, EURACTIV’s health team dives into how endocrine-disrupting chemicals (EDC) can affect children, especially in their most important developmental years. They talk with Doctor Anders Juul, a paediatric endocrinologist at Rigshospitalet in Copenhagen. He explains how children are exposed to these chemicals and the health issues this can cau…
  continue reading
 
Psilocybin, MDMA or LSD might associate with party drugs but their therapeutic value is being discovered worldwide. Ian Roullier took part in two clinical trials that looked at the effects of psilocybin on depression. Through his personal experience, Roullier shares his insights on psychedelic-assisted therapy, its potential value to patients and w…
  continue reading
 
his short new NIHR podcast series hosted by Professor William Hope, Dame Sally Davies Chair of AMR Research and Co-Lead of the NIHR Infectious Diseases National Specialty Group, brings together experts in Antimicrobial Resistance (AMR) to discuss the threat posed by AMR and what can and should be done to tackle the problem. In this third episode, W…
  continue reading
 
Interview with Benjamin H. Kaffenberger, MD, MS, author of Development of a Skin-Directed Scoring System for Stevens-Johnson Syndrome and Epidermal Necrolysis: A Delphi Consensus Exercise. Hosted by Adewole S. Adamson, MD. Related Content: Development of a Skin-Directed Scoring System for Stevens-Johnson Syndrome and Epidermal Necrolysis…
  continue reading
 
Tobacco is responsible for 8 million deaths a year but despite that governments across the world spend millions supporting tobacco farms, according to WHO Director-General Tedros Ghebreyesus. As 31 May marks World No Tobacco Day, EURACTIV’s health team talks with Rudiger Krech, WHO Director of the Health Promotion Department, on the impact of toxic…
  continue reading
 
As this week is European Testing Week, a European campaign that aims to increase testing efforts and promote awareness of the benefits of earlier hepatitis and HIV testing, EURACTIV's health team is talking with Jens Lundgren, Professor of infectious diseases at the University of Copenhagen in Denmark. He has been involved with clinical HIV researc…
  continue reading
 
This week, EURACTIV’s health team talks with Chantal Friebertshäuser, Senior Vice President at Moderna for Europe, the Middle East and Canada. They discuss the end of COVID and the new vaccine they are developing against cancer. They also talk about the new facility the biotechnology company recently opened in Madrid, Spain. This new laboratory, eq…
  continue reading
 
This short new NIHR podcast series hosted by Professor William Hope, Dame Sally Davies Chair of AMR Research and Co-Lead of the NIHR Infectious Diseases National Specialty Group, brings together experts in Antimicrobial Resistance (AMR) to discuss the threat posed by AMR and what can and should be done to tackle the problem. In this second episode,…
  continue reading
 
Loading …

Quick Reference Guide